Leor Sapir: The Questions the New York Times Refused to Ask (#27)
Leor Sapir spent months dissecting the New York Times' six-episode podcast on youth gender transition — and what he found is not a failure of journalism so much as a structured avoidance. The paper interviewed everyone who matters in this field and still never asked what gender identity actually means. In this conversation with Stella O'Malley, Mia Hughes, and Bret Alderman, Sapir walks through the evasions, the editorial choices, and the explosive admissions that never made it into the Times' coverage — and explains what the medical establishment must now decide.
The New York Times spent two years on a six-episode podcast investigating youth gender transition. It interviewed clinicians, researchers and families. It positioned itself as a sober reckoning with a contested field. And yet, according to Leor Sapir, it never once asked what gender identity actually is. That omission is the starting point for one of the most searching conversations the Beyond Gender hosts have recorded this year. Sapir is a Fellow at the Manhattan Institute and a regular contributor to City Journal, where his work on paediatric transition policy and bioethics has drawn both serious attention and controversy. He arrives at this conversation having published a two-part critique of the Times' series "The Protocol" — an analysis that argues the paper created an illusion of balanced coverage while steering listeners away from the field's most fundamental, unanswered questions. The hosts press him on exactly how that sleight of hand works, and his answers are methodical and unflinching. Central to the episode is what Sapir calls the definitional problem. If the medical field cannot define gender identity without circular reasoning — if endocrinologists are treating a condition whose core concept resists coherent description — then any clinical protocol built on that concept is compromised from the foundation up. His sharpest observation captures the absurdity plainly: imagine a medical specialism treating a condition it cannot define without falling back on the very term it is trying to explain. That, he argues, is precisely the situation the Times declined to examine. Sapir also shares details from his own interview with Laura Edwards-Leeper, a prominent clinician closely associated with gender-affirming assessment. In that conversation, she acknowledged that gender identity as used in clinical settings is grounded in stereotypes. It is a striking admission, and the fact that it remained outside the Times' reporting raises hard questions about editorial choices that O'Malley, Hughes, and Alderman are clearly keen to pursue. The episode also examines how the series treated people who have detransitioned — afforded, Sapir says, around thirty seconds — set against the considerably more adversarial treatment given to whistleblower Jamie Reed. The conversation widens to cover the institutional politics now shaping this debate. Sapir outlines a fork in the road for medical leaders: either allow professional bodies like WPATH to absorb the blame for misleading clinicians, or face a reckoning through federal investigations. It is a strategic framing that cuts through much of the noise, and it gives the discussion an unusual clarity about where accountability may eventually land. What makes this episode worth the listening time is not simply the forensic quality of Sapir's analysis, but the way the three hosts draw out the human and intellectual stakes. The conversation moves between media criticism, clinical epistemology and institutional politics without losing its thread. For anyone trying to understand why the mainstream account of youth gender medicine so often feels incomplete, this is a conversation that names what keeps being left out.
Watch and subscribe on YouTube
Open this episode on the Beyond Gender channel
